At $60 billion a year, epidemics cost far more than putting in place the systems to prepare for them.
If we put research at the heart of epidemic response, it’s a double win – helping fight outbreaks that are underway and protecting us in the future.
There's a vital set of tools to help us tackle the threat of superbugs that we're not using to their full potential. Vaccines.
In the 2019 commission, which explores the theme of outbreaks, Adrienne Surprenant tells the human story of Dengue fever.